Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.01M | -3.78M | -4.17M | -4.03M | -3.66M |
| Total Depreciation and Amortization | 398.00K | 421.00K | 414.00K | 408.00K | 405.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.00K | 76.00K | 481.00K | 513.00K | 556.00K |
| Change in Net Operating Assets | 645.00K | -143.00K | 108.00K | 138.00K | -72.00K |
| Cash from Operations | -3.96M | -3.42M | -3.17M | -2.97M | -2.77M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | -1.00K | -19.00K | -4.00K | -37.00K |
| Cash from Investing | -1.00K | -1.00K | -19.00K | -4.00K | -37.00K |
| Total Debt Issued | 500.00K | 500.00K | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.17M | 1.87M | 1.50M | 3.20M | 3.10M |
| Repurchase of Common Stock | -- | -- | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.00K | -40.00K | -36.00K | -65.00K | -66.00K |
| Cash from Financing | 3.65M | 2.33M | 1.46M | 3.13M | 3.03M |
| Foreign Exchange rate Adjustments | -9.00K | -3.00K | 10.00K | 8.00K | 5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -320.00K | -1.09M | -1.72M | 171.00K | 233.00K |